(Q40827117)

reason for preferred rank

24 September 2017

title

Chemoimmunotherapy of metastatic large bowel cancer.Nonspecific stimulation with BCG and levamisole (English)

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

1 reference

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

author name string

M. Valdivieso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

A. Bedikian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

M. A. Burgess

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

V. Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

E. M. Hersh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

G. P. Bodey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

G. M. Mavligit

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336190

26 March 2023

language of work or name

English

0 references

publication date

1 November 1977

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

1 reference

24 September 2017

volume

40

1 reference

24 September 2017

issue

5 Suppl

1 reference

24 September 2017

page(s)

2731-2739

1 reference

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

24 September 2017

cites work

1

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Fluorouracil, methyl-CCNU and vincristine in cancer of the colon

26 March 2023

4

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer

26 March 2023

5

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

26 March 2023

6

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.

26 March 2023

7

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

26 March 2023

8

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

26 March 2023

9

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

11

25

1018

Henderson

1965

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Nonparametric Estimation from Incomplete Observations

26 March 2023

13

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

Cancer Treatment Reports

16

60

1597

Macdonald

1976

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results

26 March 2023

17

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine2

26 March 2023

19

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

21

37

980

Rodriguez

1977

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Levamisole in advanced human breast cancer

26 March 2023

22

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

26 March 2023

23

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

26 March 2023

24

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

25

36

1821

Valdivieso

1976

1 reference

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

https://api.crossref.org/works/10.1002/1097-0142(197711)40:5+%3C2731::AID-CNCR2820400948%3E3.0.CO;2-W

26 March 2023

Identifiers

10.1002/1097-0142(197711)40:5+<2731::AID-CNCR2820400948>3.0.CO;2-W

1 reference

24 September 2017

1 reference